AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-31945775_ITM" title="Facts and information about Thrombolytic agents (Systemic).">Thrombolytic agents (Systemic).</a>
Close
Set up an RSS feed that alerts you when new articles from USP DI-Volume II, Advice for the Patient: Drug Information in Lay Language are available.
Frequently asked questions about RSS feeds
Thrombolytic agents (Systemic).
Some commonly used brand names are:
In the U.S. --
Abbokinase (Urokinase (yoor-oh-KYE-nase))
Abbokinase Open-Cath (Urokinase (yoor-oh-KYE-nase))
Activase (Alteplase, Recombinant (AL-ti-plase))
Eminase (Anistreplase (an-EYE-strep-lase) (Not commercially
available in Canada.))
Kabikinase (Streptokinase (strep-toe-KYE-nase))
Streptase (Streptokinase (strep-toe-KYE-nase))
In Canada --
Abbokinase (Urokinase (yoor-oh-KYE-nase)) Abbokinase Open-Cath (Urokinase (yoor-oh-KYE-nase)) Activase rt-PA (Alteplase, Recombinant (AL-ti-plase)) Lysatec rt-PA (Alteplase, Recombinant (AL-ti-plase)) Streptase (Streptokinase (strep-toe-KYE-nase))
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Competitor Analysis: Thrombolytic Agents.
- Press release article from: M2 Presswire July 14, 2008 700+ words
...July 2008-Research and Markets: Competitor Analysis: Thrombolytic Agents(C)1994-2008 M2 COMMUNICATIONS LTD RDATE:14072008...announced the addition of the "Competitor Analysis: Thrombolytic Agents" report to their offering. Product description The present...
- Neuroprotective and thrombolytic agents: advances in stroke treatment.
- Magazine article from: Journal of Neuroscience Nursing Hock, Nanette June 1, 1998 700+ words
...pharmacologic interventions, both neuroprotective agents, which make the brain less susceptible to ischemia, and thrombolytic agents, which restore blood flow to the brain, are in the later stages of clinical development. The results from these...
- Overview: hyperacute rt-PA stroke treatment. (recombinant tissue plasminogen...
- Magazine article from: Journal of Neuroscience Nursing Donnarumma, Rosario Kongable, Gail Barch, Carol Braimah, Janet Bratina, Patti Daley, Sheila Rapp, Karen Sailor, Sharion Spilker, Judith December 1, 1997 700+ words
...9,16] Recombinant tissue plasminogen...the first two thrombolytic agents approved for...urokinase, recombinant tissue plasminogen...APSAC) are thrombolytic agents which were developed...of action of thrombolytic agents is shown in Figure...cell cultures or ...
- Key Cardiology Research Presented In Stockholm: New ER-TIMI 19 Study Reports...
- Press release article from: PR Newswire August 31, 2001 700+ words
...While clot-busting, or thrombolytic, agents such as RETAVASE target only...About RETAVASE RETAVASE is a recombinant biologic cardiology care product...When compared with older thrombolytic agents, RETAVASE distinguishes itself...
- PATIENTS, SCIENTISTS PERSEVERE IN GETTING ACTIVASE ON MARKET
- Newspaper article from: The Journal Record ROBERT WATKINS March 29, 1989 700+ words
...administered intraveneously, thrombolytic agents dissolve blood clots, thus...before reaching a hospital. Thrombolytic agents, the experts say, can avert...successfully synthesized a recombinant tissue plasminogen activator...
- Prehospital Administration Of Clot-Buster Beneficial For Heart-Attack Patients.
- Newspaper article from: Drug Week October 5, 2001 700+ words
...While clot-busting, or thrombolytic, agents such as Retavase target only...blood clots. RETAVASE is a recombinant biologic cardiology care product...When compared with older thrombolytic agents, Retavase distinguishes itself...
- Clot-busting drugs to turn off heart attacks. (alteplase and streptokinase)
- Magazine article from: FDA Consumer Carey, Catherine February 1, 1988 700+ words
...have developed drugs called thrombolytic agents that can help dissolve the...one of a new class of thrombolytic agents known as tissue plasminogen...Francisco, Calif., began using recombinant DNA technology to produce...
- Bio-Technology General receives human superoxide dismutase patent.
- Press release article from: PR Newswire May 3, 1988 700+ words
...Myers Company, to commercialize recombinant superoxide dismutase. Human SOD...is its usage in conjunction with thrombolytic agents such as tPA in the treatment of myocardial...with hSOD -- in conjunction with thrombolytic agents such as tPA or angioplasty -- could...